A novel approach to the treatment of septic shock? [2]

Journal of Nutritional and Environmental Medicine

Volumn 14, Issue 1, 2004, Pages 56-57

  Wheatley, Carmen ^a  

^a Delancey Park House ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDOTE; COBAMAMIDE; CYANOCOBALAMIN; NITRIC OXIDE; RADICAL;

BLOOD PRESSURE; BRADYCARDIA; CANCER SURVIVAL; CYANIDE POISONING; HEART RATE; HUMAN; LETTER; NERVE CELL DEGENERATION; NEUROBLASTOMA; PRIORITY JOURNAL; SEPTIC SHOCK; VITAMIN BLOOD LEVEL;

EID: 2942598347     PISSN: 13590847     EISSN: None     Source Type: Journal    
DOI: 10.1080/13590840410001695202     Document Type: Letter

References (8)

1. Vincent JL, Zhang H, Szabo C, Preiser JC. Effects of nitric oxide in septic shock. Am J Resp Crit Care Med 2000; 161: 1781-5
2. Lane P, Gross SS. Nitric oxide: promiscuous and duplicitous. Sci Med 2002; 8: 96-107.
3. Brouwer M, Chamolitrat W, Ferruzig G et al. Nitric oxide interactions with cobalamins: biochemical and functional consequences. Blood 1996; 88: 1857-64.
4. Finke RG. Coenzyme B12-based chemical precedent for Co-C bond homolysis and other key elementary steps. In: Kräutler B, Arigoni D, Golding BT (eds) Vitamin B12 and B12 Proteins. La Jolla, 1998, 383-402.
5. Fenton WA, Rosenberg LE. Inherited disorders of cobalamin transport and metabolism. In: Stanbury et al. (eds) Metabolic Basis of Inherited Disease. New York, 1989, 3129-49.
6. Forsyth JC, Mueller PD, Becker CE et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. Clin Toxicol 1993; 31: 277-94.
7. Bodian M. Neuroblastoma. Pediatr Clin North Am 1959; 6: 449-72.
8. Matthews DM, Linnell JC. Vitamin B12: an area of darkness. BMA 1979; 2: 533-5.